ANGPT1 and rheumatoid arthritis: Thus, bone-targeted delivery of Novo Conj supported by HA binding affinity data (Figure 2) and bone tissue distribution of similar conjugate (Ang 1-7 conjugate) [27] offers efficacious alternative therapy for the management of RA and could be utilized for various RAS disorders.